INCB7839
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for INCB7839, covering 2025-02-19 to 2025-02-19. Get the full timeline:
Most recent: Clinical Trial Update: INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas [Phase 1]